Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imre Noth

Showing results (181-190 of 211) with videos related to

Pageof 22
Sort By:
Medrxiv : the Preprint Server for Health Sciences|November 1, 2024
Rare variants and survival of patients with idiopathic pulmonary fibrosisAitana Alonso-Gonzalez, David Jáspez, José M Lorenzo-Salazar, et al.
Cell Genomics|February 13, 2023
Leveraging global multi-ancestry meta-analysis in the study of idiopathic pulmonary fibrosis geneticsJuulia J Partanen, Paavo Häppölä, Wei Zhou, et al.
American Journal of Respiratory and Critical Care Medicine|May 31, 2024
Preacinar Arterial Dilation Mediates Outcomes of Quantitative Interstitial Abnormalities in the COPDGene StudyEileen M Harder, Pietro Nardelli, Carrie L Pistenmaa, et al.
The Lancet. Respiratory Medicine|September 25, 2017
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort studyJose D Herazo-Maya, Jiehuan Sun, Philip L Molyneaux, et al.
Research Square|February 12, 2026
Prioritizing Therapeutic Targets for Interstitial Lung Disease: A Causal Mediation AnalysisJustin Oldham, Philip Molyneaux, Manoj Maddali, et al.
American Journal of Respiratory and Critical Care Medicine|August 15, 2025
Active Antigen-Specific Adaptive Immune Responses Are Shared among Patients with Progressive Fibrotic Interstitial Lung DiseaseTania E Velez, Young Me Yoon, Vaibhav Upadhyay, et al.
Annals of the American Thoracic Society|October 15, 2024
Genomic and Serological Rheumatoid Arthritis Biomarkers, <i>MUC5B</i> Promoter Variant, and Interstitial Lung AbnormalitiesJohn S Kim, Kathryn F Flack, Vidhi Malik, et al.
Medrxiv : the Preprint Server for Health Sciences|June 29, 2026
Two Blood-based Endotypes Reveal Divergent Clinical Outcomes of Fibrotic Hypersensitivity PneumonitisYong Huang, Shwu-Fan Ma, John S Kim, et al.
The Lancet. Respiratory Medicine|January 27, 2020
Sepsis-associated acute respiratory distress syndrome in individuals of European ancestry: a genome-wide association studyBeatriz Guillen-Guio, Jose M Lorenzo-Salazar, Shwu-Fan Ma, et al.
The Lancet. Respiratory Medicine|August 19, 2022
Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association studyRichard J Allen, Justin M Oldham, David A Jenkins, et al.
Pageof 22

Showing results (181-190 of 211) with videos related to

Sort By:
Pageof 22
Medrxiv : the Preprint Server for Health Sciences|November 1, 2024
Rare variants and survival of patients with idiopathic pulmonary fibrosisAitana Alonso-Gonzalez, David Jáspez, José M Lorenzo-Salazar, et al.
Cell Genomics|February 13, 2023
Leveraging global multi-ancestry meta-analysis in the study of idiopathic pulmonary fibrosis geneticsJuulia J Partanen, Paavo Häppölä, Wei Zhou, et al.
American Journal of Respiratory and Critical Care Medicine|May 31, 2024
Preacinar Arterial Dilation Mediates Outcomes of Quantitative Interstitial Abnormalities in the COPDGene StudyEileen M Harder, Pietro Nardelli, Carrie L Pistenmaa, et al.
The Lancet. Respiratory Medicine|September 25, 2017
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort studyJose D Herazo-Maya, Jiehuan Sun, Philip L Molyneaux, et al.
Research Square|February 12, 2026
Prioritizing Therapeutic Targets for Interstitial Lung Disease: A Causal Mediation AnalysisJustin Oldham, Philip Molyneaux, Manoj Maddali, et al.
American Journal of Respiratory and Critical Care Medicine|August 15, 2025
Active Antigen-Specific Adaptive Immune Responses Are Shared among Patients with Progressive Fibrotic Interstitial Lung DiseaseTania E Velez, Young Me Yoon, Vaibhav Upadhyay, et al.
Annals of the American Thoracic Society|October 15, 2024
Genomic and Serological Rheumatoid Arthritis Biomarkers, <i>MUC5B</i> Promoter Variant, and Interstitial Lung AbnormalitiesJohn S Kim, Kathryn F Flack, Vidhi Malik, et al.
Medrxiv : the Preprint Server for Health Sciences|June 29, 2026
Two Blood-based Endotypes Reveal Divergent Clinical Outcomes of Fibrotic Hypersensitivity PneumonitisYong Huang, Shwu-Fan Ma, John S Kim, et al.
The Lancet. Respiratory Medicine|January 27, 2020
Sepsis-associated acute respiratory distress syndrome in individuals of European ancestry: a genome-wide association studyBeatriz Guillen-Guio, Jose M Lorenzo-Salazar, Shwu-Fan Ma, et al.
The Lancet. Respiratory Medicine|August 19, 2022
Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association studyRichard J Allen, Justin M Oldham, David A Jenkins, et al.
Pageof 22